Amorchem
Overview
AmorChem is an early stage life science venture capital fund, which is a major supporter of Quebec's academic innovation. The fund mainly focuses on pre-seed and seed investments with the aim of creating startup companies around groundbreaking technologies | AmorChem est un fonds d'investissement en capital de risque au stade précoce de développement, qui supporte principalement l'innovation académqiue québécoise en science de la vie. Le fonds effectue principalement des investissements de pré-démarrage et démarrage, en vue de créer des entreprises développant des percées technologiques.
Investment Focus
- Focus on life science projects from Quebec-based universities and research centres
- Active management and support for portfolio companies
- Seed and early-stage funding
Portfolio Companies
Reach Amorchem directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Amorchem
What sectors does Amorchem invest in?
Amorchem invests in Healthcare, Pharmaceuticals and Biotechnology, and is based in Westmount, Quebec, Canada. Amorchem is listed as a venture capital in the ConnectSafely investor database.
What stage does Amorchem invest at?
Amorchem backs companies at Seed and Early Stage, writing cheques of 250K - 5M.
Which regions does Amorchem invest in?
Amorchem invests across Canada.
What companies has Amorchem invested in?
Amorchem's portfolio includes Mperia Therapeutics Inc., SemaThera Inc., Corbin Therapeutics Inc., SpecificiT Pharma Inc. and Eosinate Therapeutics Inc..
How do I contact Amorchem?
Amorchem's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
